Phase II Trial of 5-FU, Leucovorin, Gemcitabine, and Cisplatin for Adenocarcinomas of the Urothelial Tract and Urachal Remnant.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 22 Dec 2016
At a glance
- Drugs Cisplatin (Primary) ; Fluorouracil (Primary) ; Folinic acid (Primary) ; Gemcitabine (Primary)
- Indications Urogenital cancer
- Focus Therapeutic Use
- 19 Dec 2016 Planned primary completion date changed from 1 Feb 2017 to 1 Feb 2018.
- 18 Dec 2015 Study design changed from Parallel to Single group assignment as reported by ClinicalTrials.gov.
- 18 Dec 2013 Planned end date changed from 1 Feb 2014 to 1 Feb 2015 as reported by ClinicalTrials.gov.